tirzepatide surmount-1 nejm 2022 weight loss percent Trial — 22.5% surmount-1 tirzepatide weight loss percent
Description
We thank the study participants

The purpose is to let your body adjust to the medication and identify any adverse reactions at the lowest effective dose
Patients should undergo comprehensive assessment by a qualified healthcare professional, including baseline investigations (HbA1c, lipid profile, liver and kidney function, thyroid function) and screening for contraindications
A Smarter Weight Loss and Longevity Formula The Tirzepatide/NAD+ combo builds on Tirzepatides weight management power while adding cellular renewal through NAD+

You cannot use Mounjaro if you're allergic to tirzepatide or any other ingredients, under 18 years old, pregnant or breastfeeding, or over 75 years old (due to increased risk of side effects)

If your tirzepatide has been exposed to temperatures above 30C (86F) , even for a few hours, it's best to discard the pen or vial and get a new, cold one from your refrigerator or the pharmacy
